Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis.

Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A.

J Urol. 1997 Dec;158(6):2069-73.

PMID:
9366314
2.

Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.

Zerwekh JE, Odvina CV, Wuermser LA, Pak CY.

J Urol. 2007 Jun;177(6):2179-84.

PMID:
17509313
3.

The effect of varying molar ratios of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss.

Ruml LA, Wuermser LA, Poindexter J, Pak CY.

J Clin Pharmacol. 1998 Nov;38(11):1035-41.

PMID:
9824785
4.

Physicochemical action of potassium-magnesium citrate in nephrolithiasis.

Pak CY, Koenig K, Khan R, Haynes S, Padalino P.

J Bone Miner Res. 1992 Mar;7(3):281-5.

PMID:
1585829
5.
6.

Effect of varying doses of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss.

Ruml LA, Gonzalez G, Taylor R, Wuermser LA, Pak CY.

Am J Ther. 1999 Jan;6(1):45-50.

PMID:
10423646
7.

Citrate salts for preventing and treating calcium containing kidney stones in adults.

Phillips R, Hanchanale VS, Myatt A, Somani B, Nabi G, Biyani CS.

Cochrane Database Syst Rev. 2015 Oct 6;(10):CD010057. doi: 10.1002/14651858.CD010057.pub2. Review.

PMID:
26439475
8.

The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.

Jaipakdee S, Prasongwatana V, Premgamone A, Reungjui S, Tosukhowong P, Tungsanga K, Suwantrai S, Noppawinyoowong C, Maskasame S, Sriboonlue P.

J Med Assoc Thai. 2004 Mar;87(3):255-63.

PMID:
15117041
9.

Effect of potassium magnesium citrate on thiazide-induced hypokalemia and magnesium loss.

Ruml LA, Pak CY.

Am J Kidney Dis. 1999 Jul;34(1):107-13.

PMID:
10401023
10.
11.

Citrate and renal calculi: new insights and future directions.

Pak CY.

Am J Kidney Dis. 1991 Apr;17(4):420-5.

PMID:
2008910
12.

Prevention of thiazide-induced hypokalemia without magnesium depletion by potassium-magnesium-citrate.

Odvina CV, Mason RP, Pak CY.

Am J Ther. 2006 Mar-Apr;13(2):101-8.

PMID:
16645424
13.

Can citrate therapy prevent nephrolithiasis?

Abdulhadi MH, Hall PM, Streem SB.

Urology. 1993 Mar;41(3):221-4.

PMID:
8442301
14.
15.

Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.

Stoller ML, Chi T, Eisner BH, Shami G, Gentle DL.

J Urol. 2009 Mar;181(3):1140-4. doi: 10.1016/j.juro.2008.11.020. Epub 2009 Jan 18.

PMID:
19152919
16.
17.
18.

[Effect of potassium citrate in the prophylaxis of urinary lithiasis].

Jiménez Verdejo A, Arrabal Martín M, Miján Ortiz JL, Hita Rosino E, Palao Yago F, Zuluaga Gómez A.

Arch Esp Urol. 2001 Nov;54(9):1036-46. Spanish.

PMID:
11789361
19.

Randomized trial of allopurinol in the prevention of calcium oxalate calculi.

Ettinger B, Tang A, Citron JT, Livermore B, Williams T.

N Engl J Med. 1986 Nov 27;315(22):1386-9.

PMID:
3534570
20.

Dosage of potassium citrate in the correction of urinary abnormalities in pediatric distal renal tubular acidosis patients.

Domrongkitchaiporn S, Khositseth S, Stitchantrakul W, Tapaneya-olarn W, Radinahamed P.

Am J Kidney Dis. 2002 Feb;39(2):383-91.

PMID:
11840381

Supplemental Content

Support Center